Shih Shang Chen
Keine laufenden Positionen mehr
Profil
Shih Shang Chen served as an Independent Director at Taiwan Liposome Co., Ltd.
He was the Head of Drug Development at Development Center for Biotechnology from 2000 to 2005.
From 2005 to 2009, he worked as Vice President at OBI Pharma, Inc. Chen holds a doctorate degree from Purdue University and an undergraduate degree from National Tsing-Hua University.
Ehemalige bekannte Positionen von Shih Shang Chen
| Unternehmen | Position | Ende |
|---|---|---|
| OBI PHARMA, INC. | Corporate Officer/Principal | 01.10.2009 |
Development Center for Biotechnology
 Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Corporate Officer/Principal | 01.01.2005 |
| TAIWAN LIPOSOME COMPANY, LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Shih Shang Chen
| Purdue University | Doctorate Degree |
| National Tsing-Hua University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OBI PHARMA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
Development Center for Biotechnology
Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Health Services |
